Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Leukocytosis Market Growth Potential: How Will Market Size Shift Through 2030?
The leukocytosis market size has experienced robust growth in recent years. This market is projected to expand from $5.13 billion in 2025 to reach $5.41 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 5.4%. Key factors contributing to this historical growth include the widespread occurrence of infectious diseases, a rising incidence of inflammatory disorders, an increase in leukemia cases, the dependence on traditional blood tests, and the expansion of diagnostic services offered in hospitals.
The leukocytosis market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $6.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This anticipated growth is driven by several factors, including breakthroughs in hematology diagnostics, the increasing embrace of personalized treatment strategies, heightened public awareness concerning early disease identification, greater healthcare spending, and the expansion of automated laboratory processes. Key developments expected during this period involve the wider implementation of sophisticated blood diagnostics, an intensified focus on treatments tailored to specific underlying diseases, the escalating application of precision medicine within hematology, the proliferation of automated and high-throughput testing methods, and the growing incorporation of clinical decision support systems.
Get A Free Sample Report With In-Depth Market Insights:
Leukocytosis Market Growth Factors: What’s Supporting Expansion?
The increasing occurrence of blood-related conditions is anticipated to propel the growth of the leukocytosis market going forward. These medical conditions affect blood components, including red blood cells, white blood cells, platelets, or plasma. The incidence of blood-related diseases is rising due to aging populations, as older adults are more susceptible to conditions such as anemia, leukemia, and clotting disorders because of declining immune function and cumulative health issues. Blood-related diseases frequently lead to elevated white blood cell counts, a characteristic sign of leukocytosis, emphasizing the need for enhanced early diagnosis, improved monitoring tools, and more effective treatment options. For instance, in 2024, according to the American Cancer Society, a US-based cancer organization, there were 62,770 new cases of leukemia reported, marking a significant increase from 59,610 cases in 2023. Therefore, the rise in the incidence of blood-related diseases is driving the growth of the leukocytosis market.
Leukocytosis Market Segmentation And Category Overview
The leukocytosis market covered in this report is segmented –
1) By Disease Type: Infection, Leukemia
2) By Diagnosis Type: Blood Tests, Bone Marrow Biopsy
3) By End User: Hospitals, Diagnostic Laboratories
Subsegments:
1) By Infection: Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections
2) By Leukemia: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia (ALL) with Hyperleukocytosis
Leukocytosis Market Industry Trends: What’s Reshaping Demand?
Major companies operating in the leukocytosis market are increasingly focusing on integrating artificial intelligence into diagnostic systems to enhance early disease detection, improve diagnostic accuracy, and facilitate personalized treatment planning. Artificial intelligence in diagnostic systems refers to the application of AI technologies such as machine learning, deep learning, and natural language processing to analyze medical data, thereby supporting or automating disease diagnosis. For instance, in December 2024, Koninklijke Philips NV, a Netherlands-based healthcare company, launched its CT 5300 system. This system incorporates proprietary artificial intelligence (AI) technologies to optimize computed tomography (CT) imaging workflows. The CT 5300 features a computed tomography smart workflow, which includes AI-driven tools like precise position, precise cardiac, and precise brain, designed to streamline scan preparation, heighten diagnostic accuracy, and reduce patient radiation exposure.
Leukocytosis Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the leukocytosis market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis International AG, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Beckman Coulter Diagnostics Inc., Bio-Rad Laboratories, Bio-Techne Corporation, NeoGenomics Laboratories Inc., DiaSorin S.p.A.
View The Full Leukocytosis Market Report:
Leukocytosis Market Geographic Spread And Regional Opportunities
North America was the largest region in the leukocytosis market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the leukocytosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
